
    
      The primary objective of this study is to assess the effectiveness and safety of ReCellÂ® with
      skin graft (experiment group) vs. skin graft (control group) for the treatment of non-healing
      diabetic foot ulcers. Our hypothesis is that the methods of experiment group is better than
      the control group.
    
  